Delivery Order SPE2DB20D1110-SPE2DB25FJ70D
Award Date
10/21/24
Potential Completion Date
10/22/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,019.11 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets. The contract has a period of performance through November 16, 2022 and was awarded on November 15, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4 mg Glimepiride tablets to the Defense Logistics Agency (DLA). The $7,283.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,771.57 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has a completion date of July 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,102.86, is a delivery order for 4,566,812,305 units of the drug Glimepiride 4 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,626,104 Glimepiride 4 mg tablets. The firm-fixed-price delivery order, valued at $4,039.92, has an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,206.32 firm fixed-price contract is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has a completion date of February 25, 2025 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,447.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 4 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,316.81 firm fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat type 2 diabetes. The award has an ultimate completion date of December 30, 2024 and was made on December 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,546.94 Firm Fixed Price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 23, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $2,235.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order, with a firm-fixed price pricing type, and the ultimate completion date is April 23, 2025. The contract is for the delivery of 4,567,997,993 units of the medication Glimepiride 4 mg tablet in 100-count packages. This award does not have a set-aside designation, indicating open competition....